![]() | |
Clinical data | |
---|---|
Trade names | Thiotriazoline; Tiokor |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.244.688 |
Chemical and physical data | |
Formula | C5H7N3O2S |
Molar mass | 173.19 g·mol−1 |
3D model ( JSmol) | |
| |
|
Tiazotic acid (brand names Thiotriazoline and Tiokor) is an antioxidant. It is used as a pharmaceutical drug for the treatment of ischemic heart disease in Russia, Ukraine, and Uzbekistan. [1] [2]
It is used as its salt with morpholine. [3]
It has been studied for its potential to improve the cardiac effects of COVID-19. [4]
![]() | |
Clinical data | |
---|---|
Trade names | Thiotriazoline; Tiokor |
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.244.688 |
Chemical and physical data | |
Formula | C5H7N3O2S |
Molar mass | 173.19 g·mol−1 |
3D model ( JSmol) | |
| |
|
Tiazotic acid (brand names Thiotriazoline and Tiokor) is an antioxidant. It is used as a pharmaceutical drug for the treatment of ischemic heart disease in Russia, Ukraine, and Uzbekistan. [1] [2]
It is used as its salt with morpholine. [3]
It has been studied for its potential to improve the cardiac effects of COVID-19. [4]